These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 10580640

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock.
    Krakauer T.
    Toxins (Basel); 2010 Aug; 2(8):1963-83. PubMed ID: 22069668
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.
    Krakauer T.
    Toxins (Basel); 2012 Nov 15; 4(11):1343-66. PubMed ID: 23202320
    [Abstract] [Full Text] [Related]

  • 5. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
    Hogan RJ, VanBeek J, Broussard DR, Surman SL, Woodland DL.
    J Immunol; 2001 Jun 01; 166(11):6514-22. PubMed ID: 11359802
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The bacterial superantigen and superantigen-like proteins.
    Fraser JD, Proft T.
    Immunol Rev; 2008 Oct 01; 225():226-43. PubMed ID: 18837785
    [Abstract] [Full Text] [Related]

  • 9. Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1.
    Shimonkevitz R, Boen E, Malmstrom S, Brown E, Hurley JM, Kotzin BL, Matsumura M.
    Infect Immun; 1996 Apr 01; 64(4):1133-9. PubMed ID: 8606069
    [Abstract] [Full Text] [Related]

  • 10. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
    Tokura Y, Yagi J, O'Malley M, Lewis JM, Takigawa M, Edelson RL, Tigelaar RE.
    J Invest Dermatol; 1994 Jan 01; 102(1):31-8. PubMed ID: 8288908
    [Abstract] [Full Text] [Related]

  • 11. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G, Levy R, Hillman D, Kaempfer R.
    Nat Med; 2000 Apr 01; 6(4):414-21. PubMed ID: 10742148
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
    Schlievert PM, Cahill MP, Hostager BS, Brosnahan AJ, Klingelhutz AJ, Gourronc FA, Bishop GA, Leung DYM.
    mBio; 2019 Mar 19; 10(2):. PubMed ID: 30890614
    [Abstract] [Full Text] [Related]

  • 14. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.
    Rich RR, Mollick JA, Cook RG.
    Trans Am Clin Climatol Assoc; 1990 Mar 19; 101():195-204; discussion 204-6. PubMed ID: 2577245
    [Abstract] [Full Text] [Related]

  • 15. Superantigens: structure and relevance to human disease.
    Johnson HM, Torres BA, Soos JM.
    Proc Soc Exp Biol Med; 1996 Jun 19; 212(2):99-109. PubMed ID: 8650257
    [Abstract] [Full Text] [Related]

  • 16. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
    Norton SD, Schlievert PM, Novick RP, Jenkins MK.
    J Immunol; 1990 Mar 15; 144(6):2089-95. PubMed ID: 2313089
    [Abstract] [Full Text] [Related]

  • 17. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
    Hurley JM, Shimonkevitz R, Hanagan A, Enney K, Boen E, Malmstrom S, Kotzin BL, Matsumura M.
    J Exp Med; 1995 Jun 01; 181(6):2229-35. PubMed ID: 7760008
    [Abstract] [Full Text] [Related]

  • 18. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
    Pontzer CH, Russell JK, Johnson HM.
    Proc Natl Acad Sci U S A; 1991 Jan 01; 88(1):125-8. PubMed ID: 1986357
    [Abstract] [Full Text] [Related]

  • 19. Staphylococcal TSST-1 Association with Eczema Herpeticum in Humans.
    Schlievert PM, Roller RJ, Kilgore SH, Villarreal M, Klingelhutz AJ, Leung DYM.
    mSphere; 2021 Aug 25; 6(4):e0060821. PubMed ID: 34319127
    [Abstract] [Full Text] [Related]

  • 20. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW, Laupland KB, Chow AW.
    Can J Microbiol; 2000 Feb 25; 46(2):171-9. PubMed ID: 10721486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.